Member Info for MIKODX

So a big week with news finally in of the stroke test. This was supposed to be the mother of all news. This news was supposed to blow the SP to over a pound, I heard some on here saying. Well it didn't , and it's not going to either. But what we did see was a 200% rise and that's great. Hopefully we can find a new support level at this level and move up some more as news starts coming in. We now await the publishing date for the CYP2C19-ID test due in July, and the full and final recommendation for the AIHL which could come anytime now.

These recommendations are actually becoming a bit of a joke. The AIHL which was given final recommendation clearance last year, we now discover was only a conditional recommendation with full and final recommendations to come this year. The stroke test recommendations which will be announced in May, I suppose will again be a conditional recommendation with full and final recommendations to follow. The amount of recommendations these tests have to go through, you have to wonder when and if they will ever get finally recommended. Either way lots to look forward to this year, hopefully improved Sales, and more importantly lots of positive news. As we know sentiment and news is a big factor in driving the stock up.

Holding patiently.

Yes it's looks like it's going that way. It's been a sell off all week, although the buying did pick up towards the end when it dropped below 30. If that continues onto next week, then 30 could become the new support level, although I very much doubt it, the market looks depressing atm. Either way surely we must be close to some takeover news. The 28 day FSP period is officially over, although that doesn't apply due to the dispensation. The longer this goes on, the more we're looking at stalemate.

Johnboi1968 - The rate this is going a lot of us will be getting your last option. A big uplift in the distribution and expansion of the AIHL test, home and abroad, is the best thing we have right now that will get this SP really moving. I hope Mr Cheek delivers.

And I'm not talking about the Nasdaq, I'm talking American Pink sheets.

Last year this time the SP was 87p, in July it hit a high of £1.45. only 3 years ago the SP was £11.75. Then in the space of a year it drops to 10p. Unbelievable. Now I understand that AIM stocks can be very volatile but how do you go from £11.75 to 10p in under three years? Something very very fishy. MMs playing with the SP however they like and the FCA and all these other impotent organisations say and do sweet nothing. The AIM is the biggest pile of poo out of all the markets in the world. Rip off Britain is an under statement, it's an utter disgrace. You stand more chance with the American market and thats a fact.

Trickymatters - I've got a funny feeling the bid will be coming from Mount Sinai School Of Medicine, they already own 16% of the Share capital. Here's another reason:

https://reports.mountsinai.org/article/neph2022-_1_renalytix-goes-into-clinical-use

Good lord, what a huge drop. Glad I got out a couple of weeks ago. Welcome to AIM.

Good to see an improvement in Sales, although the numbers could and should have been better, but I suppose any steps forward is positive news. Don't understand why he would need to raise funds with the drawdown facility still in place, any further dilution will see this company sink further down with next to nothing coming in. This company had a good track record when it came to raising funds without heavy dilution. I hope Mr Cheek bears that in mind when he goes about the next fundraise.

We've also broken our year high, which is great. Next step, our two year high of 5.6. If we can break that, then a breakout could well be on the cards.

Good to see this on the rise, CNSL were grossly undervalued, it's about time this re-rated. I wouldn't be surprised if we see 10p this year which is roughly where this should be. Ignore what the derampers and the people that like to put this company down say, but 10p is where we should be. Still a long way to go before It hits my average, but if this continues to climb the way it is, we could get there within the year. Long may the climb continue.

Pop my head in for a second and all I see are the usual suspects going at each other like nobody’s business. How sad is that? Well, at least we have a nice steady rise happening to cheer us up. It might be very small steps forward, but it’s long as it’s heading North I don’t mind how slow it goes.

They were super legit, that's why they were given the contract. It wasn't Omega's fault that the deal collapsed, it was the govt's, who promised to sell Omega's test but then changed their minds and went elsewhere. Thats not the company's fault, this is still a good company with a decent business and next to nothing debt.

Tradesin - Wrong. The CEO bought three tranches of shares back in 2023, two in May and the last one being in August. Stop spreading misinformation.

Anyone new here looking to earn on their investments, now is a good time to be getting into this Share. I see this SP doubling within the year. But don't take my word for it, dyor.

Atanasoff- If you had a brain, you'd be dangerous, and the Captain doesn't know whether he's coming or going. I've been here long enough to know exactly what this company is about. I dont believe or listen to the waffle that comes out the Captain's mouth, he's just bitter because he's lost a lot of money and given up hope. Best to take no notice of these emotional types, their views are always based on their emotions and not facts.

Captain - Read the annual reports, it's all in there.

I would say were worth at least double of our current mcap. Forget the snake oil you speak of anyone's guess what that is. The companies business and assets alone are worth much more than the current market value.

It's because the drop was overdone, and the govt dispute pushed it further down. Now that were out of Covid and things are settling back down, maybe our true value is being realised by the market. We're very undervalued at the moment, so things maybe starting to align as they should.

Dont forget -

RNS Number : 4140F

Renalytix PLC

04 March 2024

Renalytix plc (NASDAQ: RNLX) (LSE: RENX), an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease to drive improved patient outcomes and advance value-based care provides the following update in regard to an unsolicited approach from a possible strategic acquiror, launch of a Formal Sale Process, and its advanced financing activities.

Formal Sale Process

Renalytix has received an unsolicited approach from a large and well-capitalised publicly listed strategic diagnostics company, which is in the process of evaluating an acquisition of the entire issued, and to be issued, share capital of the Company.

Therefore, the Company has commenced a review of all available options, including a possible sale of the Company and/or its assets, and has commenced a formal sale process (as referred to in Note 2 on Rule 2.6 of the City Code on Takeovers and Mergers) (the "Formal Sale Process"). The Formal Sale Process will enable the Board and its advisers to conduct an orderly process and engage more widely with all potentially interested parties, with a view to optimising the outcome for Renalytix's shareholders. It remains possible that, following completion of the Formal Sale Process, the Board will consider that Renalytix and its shareholders would be best served by alternative strategic options available to the Company, including by Renalytix continuing to trade on AIM and Nasdaq as an independent entity.

Plenty of buying going on, high volume too.